One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes
- PMID: 12598308
- PMCID: PMC1868096
- DOI: 10.1016/S0002-9440(10)63870-9
One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes
Abstract
The prognostic significance of somatic activating codon 816 c-kit mutations in pediatric urticaria pigmentosa has not yet been established in detail. Detection of such mutations in archival paraffin-embedded biopsies is usually hampered by an abundance of surrounding normal cells. Here we describe a method for the selective amplification and specific detection of c-kit mutation Asp816-->Val in complete tissue sections cut from up to 24-year-old paraffin blocks. Peptide nucleic acid-mediated polymerase chain reaction clamping of the wild-type allele was combined with on-line mutation detection using oligonucleotide hybridization probes. In DNA extracted from HMC-1 cells heterozygously carrying the c-kit mutation Asp816-->Val, the one-tube assay allowed specific detection of this mutation in a more than 1000-fold excess of normal background DNA within 1 hour and without the need for additional analytical steps. In a series of 38 cases with pediatric urticaria pigmentosa we detected c-kit codons 815 and 816 mutations in 16 cases. Mutation detection did not correlate with clinical outcome after a mean follow-up of 11.2 years. In conclusion, the procedure described may represent an ideal screening tool for all kinds of clinical applications, using point mutations as markers of, for example, early events in carcinogenesis, circulating metastatic tumor cells, and minimal residual disease.
Figures




Similar articles
-
Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.Hum Pathol. 2005 May;36(5):486-93. doi: 10.1016/j.humpath.2005.03.015. Hum Pathol. 2005. PMID: 15948115
-
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.J Clin Invest. 1993 Oct;92(4):1736-44. doi: 10.1172/JCI116761. J Clin Invest. 1993. PMID: 7691885 Free PMC article.
-
Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations.Am J Dermatopathol. 2013 Feb;35(1):113-6. doi: 10.1097/DAD.0b013e31826330bf. Am J Dermatopathol. 2013. PMID: 22892471 Review.
-
Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.Nat Genet. 1996 Mar;12(3):312-4. doi: 10.1038/ng0396-312. Nat Genet. 1996. PMID: 8589724
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
Cited by
-
Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies.Virchows Arch. 2005 Dec;447(6):909-19. doi: 10.1007/s00428-005-0069-1. Epub 2005 Oct 18. Virchows Arch. 2005. PMID: 16231178 Review.
-
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.J Clin Pathol. 2004 Jun;57(6):604-8. doi: 10.1136/jcp.2003.014860. J Clin Pathol. 2004. PMID: 15166264 Free PMC article.
-
Systemic Mastocytosis: Multidisciplinary Approach.Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021068. doi: 10.4084/MJHID.2021.068. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34804442 Free PMC article. Review.
-
Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.Leukemia. 2014 May;28(5):1103-12. doi: 10.1038/leu.2013.307. Epub 2013 Oct 23. Leukemia. 2014. PMID: 24153014
-
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel.Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):582-594. doi: 10.1016/j.htct.2022.04.006. Epub 2022 May 26. Hematol Transfus Cell Ther. 2022. PMID: 35688791 Free PMC article.
References
-
- Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nunez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001, 25:603-625 - PubMed
-
- Lennert K, Parwaresch MR: Mast cells and mast cell neoplasia: a review. Histopathology 1979, 3:349-365 - PubMed
-
- Horny HP, Parwaresch MR, Lennert K: Bone marrow findings in systemic mastocytosis. Hum Pathol 1985, 16:808-814 - PubMed
-
- Stein DH: Mastocytosis: a review. Pediatr Dermatol 1986, 3:365-375 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources